Literature DB >> 16221676

G betagamma binds histone deacetylase 5 (HDAC5) and inhibits its transcriptional co-repression activity.

Bryan D Spiegelberg1, Heidi E Hamm.   

Abstract

In a yeast two-hybrid screen designed to identify novel effectors of the G betagamma subunit of heterotrimeric G proteins, we found that G betagamma binds to histone deacetylase 5 (HDAC5), an enzyme involved in a pathway not previously recognized to be directly impacted by G proteins. Formation of the G beta1gamma2-HDAC5 complex in mammalian cells can be blocked by overexpression of G alpha(o), and this inhibition is relieved by activation of alpha2A-adrenergic receptor, suggesting that the interaction occurs in a signal-dependent manner. The C-terminal domain of HDAC5 binds directly to G betagamma through multiple motifs, and overexpression of this domain mimics the C terminus of G protein-coupled receptor kinase 2, a known G betagamma scavenger, in its ability to inhibit the G betagamma/HDAC5 interaction. The C terminus of HDAC4 shares significant similarity with that of HDAC5, and accordingly, HDAC4 is also able to form complexes with G beta1gamma2 in cultured cells, suggesting that the C-terminal domain of class II HDACs is a general G betagamma binding motif. Activation of a G(i/o)-coupled receptor results in a time-dependent activation of MEF2C, an HDAC5-regulated transcription factor, whereas inhibition of the interaction with a G betagamma scavenger inhibits MEF2C activity, suggesting a reduced potency of HDAC5-mediated inhibition. Taken together, these data imply that HDAC5 and possibly other class II HDACs can be added to the growing list of G betagamma effectors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221676     DOI: 10.1074/jbc.M504066200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Distribution of activator of G-protein signaling 3 within the aggresomal pathway: role of specific residues in the tetratricopeptide repeat domain and differential regulation by the AGS3 binding partners Gi(alpha) and mammalian inscuteable.

Authors:  Ali Vural; Sadik Oner; Ningfei An; Violaine Simon; Dzwokai Ma; Joe B Blumer; Stephen M Lanier
Journal:  Mol Cell Biol       Date:  2010-01-11       Impact factor: 4.272

Review 2.  G protein βγ subunits: central mediators of G protein-coupled receptor signaling.

Authors:  A V Smrcka
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

Review 3.  Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling.

Authors:  George Vaniotis; Bruce G Allen; Terence E Hébert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

Review 4.  Heterotrimeric G protein-mediated signaling and its non-canonical regulation in the heart.

Authors:  Peng Zhang; Celinda M Kofron; Ulrike Mende
Journal:  Life Sci       Date:  2015-03-26       Impact factor: 5.037

5.  Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling.

Authors:  Jean-Claude Twizere; Jean-Yves Springael; Mathieu Boxus; Arsène Burny; Franck Dequiedt; Jean-François Dewulf; Julie Duchateau; Daniel Portetelle; Patrice Urbain; Carine Van Lint; Patrick L Green; Renaud Mahieux; Marc Parmentier; Luc Willems; Richard Kettmann
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

6.  RACK1 regulates angiotensin II-induced contractions of SHR preglomerular vascular smooth muscle cells.

Authors:  Xiao Zhu; Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-18

7.  Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis.

Authors:  Guoquan Liu; Jingyan Han; Jasmina Profirovic; Elena Strekalova; Tatyana A Voyno-Yasenetskaya
Journal:  Angiogenesis       Date:  2008-12-18       Impact factor: 9.596

Review 8.  Shuttling and translocation of heterotrimeric G proteins and Ras.

Authors:  Deepak K Saini; Mariangela Chisari; N Gautam
Journal:  Trends Pharmacol Sci       Date:  2009-05-06       Impact factor: 14.819

9.  Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC.

Authors:  Ganchimeg Ishdorj; Bonnie A Graham; Xiaojie Hu; Jing Chen; James B Johnston; Xianjun Fang; Spencer B Gibson
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

10.  RGS9-2--controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states.

Authors:  Vasiliki Mitsi; Dimitra Terzi; Immanuel Purushothaman; Lefteris Manouras; Sevasti Gaspari; Rachael L Neve; Maria Stratinaki; Jian Feng; Li Shen; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.